PLK1 is reported to enhance anoikis resistance via inhibiting β-catenin degradation in esophageal squamous cell carcinoma, and inhibition of PLK1 could trigger cell apoptosis to block LUAD progression [26–28]. Here, PLK1 is linked to esophageal squamous cell carcinoma.